Eugia US LLC is voluntarily recalling medroxyPROGESTERone Acetate Injectable Suspension, USP (150mg per mL), a prescription hormonal medication. Approximately 19,872 vials are affected by this recall because the manufacturing process did not meet required quality standards (CGMP deviations). No injuries or adverse events have been reported to date, but the company is recalling the lot as a precaution to ensure patient safety.
Because of deviations from Good Manufacturing Practices, the quality, safety, and purity of this injectable medication cannot be guaranteed. Using a drug that does not meet strict manufacturing standards could result in treatment that is less effective or poses unknown health risks.
Manufactured in India for Eugia US LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.